Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies 2021-10-28 21:00
HanAll Biopharma Reports Third Quarter 2021 Results 2021-10-28 21:00
BioVaxys Further Expands Intellectual Property Portfolio in Global Markets 2021-10-28 20:00
Interim report for Q3 2021 : Bactiguard Holding AB (publ) 2021-10-28 15:23
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility 2021-10-28 08:30
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:08
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:06
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 22:03
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients 2021-10-27 21:25
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients 2021-10-27 20:47
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom 2021-10-27 20:30
Abcam completes $340m strategic acquisition and expands kit capacity and capability 2021-10-27 14:00
I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China 2021-10-26 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 2021-10-26 07:30
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage 2021-10-25 20:30
Antengene to Host its First R&D Days on November 16 and November 18, 2021 2021-10-25 20:00
Happiness Biotech Acquires Majority Ownership in Fujian Shennong 2021-10-25 20:00
GC Group strengthens Sustainable Growth for business and customers with "Together To Net Zero" Roadmap 2021-10-25 19:05
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer 2021-10-25 17:00
1 202 203 204 205 206 440